Rock Springs Capital Management as of March 31, 2018
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 148 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
UnitedHealth (UNH) | 4.5 | $104M | 488k | 214.00 | |
Intuitive Surgical (ISRG) | 2.5 | $59M | 144k | 412.83 | |
Abbvie (ABBV) | 2.4 | $57M | 600k | 94.65 | |
Alexion Pharmaceuticals | 2.3 | $54M | 485k | 111.46 | |
Neurocrine Biosciences (NBIX) | 2.1 | $50M | 606k | 82.93 | |
Acadia Healthcare (ACHC) | 2.1 | $49M | 1.3M | 39.18 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.1 | $49M | 1.9M | 25.55 | |
Molina Healthcare (MOH) | 2.0 | $47M | 576k | 81.18 | |
Spark Therapeutics | 1.8 | $42M | 624k | 66.59 | |
Bristol Myers Squibb (BMY) | 1.8 | $41M | 650k | 63.25 | |
Gw Pharmaceuticals Plc ads | 1.7 | $41M | 360k | 112.67 | |
Aetna | 1.7 | $40M | 239k | 169.00 | |
Madrigal Pharmaceuticals (MDGL) | 1.6 | $38M | 326k | 116.79 | |
Beigene (BGNE) | 1.6 | $37M | 221k | 168.00 | |
Hca Holdings (HCA) | 1.6 | $37M | 380k | 97.00 | |
Loxo Oncology | 1.6 | $37M | 317k | 115.37 | |
Radius Health | 1.5 | $36M | 1.0M | 35.94 | |
Pacira Pharmaceuticals (PCRX) | 1.5 | $35M | 1.1M | 31.15 | |
Tesaro | 1.4 | $33M | 573k | 57.14 | |
Pra Health Sciences | 1.4 | $33M | 395k | 82.96 | |
Irhythm Technologies (IRTC) | 1.3 | $30M | 478k | 62.95 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $30M | 181k | 162.98 | |
Stryker Corporation (SYK) | 1.2 | $29M | 178k | 160.92 | |
Puma Biotechnology (PBYI) | 1.2 | $28M | 413k | 68.05 | |
Penumbra (PEN) | 1.2 | $28M | 243k | 115.65 | |
Celgene Corporation | 1.2 | $28M | 310k | 89.21 | |
DaVita (DVA) | 1.1 | $27M | 408k | 65.94 | |
Edwards Lifesciences (EW) | 1.1 | $27M | 190k | 139.52 | |
WellCare Health Plans | 1.1 | $26M | 134k | 193.63 | |
AmerisourceBergen (COR) | 1.1 | $25M | 295k | 86.21 | |
Thermo Fisher Scientific (TMO) | 1.0 | $24M | 115k | 206.46 | |
Gilead Sciences (GILD) | 1.0 | $24M | 313k | 75.39 | |
Teleflex Incorporated (TFX) | 1.0 | $24M | 93k | 254.98 | |
Avexis | 1.0 | $24M | 190k | 123.58 | |
Medicines Company | 1.0 | $23M | 690k | 32.94 | |
Epizyme | 1.0 | $23M | 1.3M | 17.75 | |
Assembly Biosciences | 0.9 | $22M | 443k | 49.14 | |
Mersana Therapeutics (MRSN) | 0.9 | $21M | 1.3M | 15.77 | |
Wright Medical Group Nv | 0.8 | $20M | 1.0M | 19.84 | |
Alder Biopharmaceuticals | 0.8 | $19M | 1.5M | 12.70 | |
Baxter International (BAX) | 0.8 | $19M | 297k | 65.04 | |
Sarepta Therapeutics (SRPT) | 0.8 | $19M | 258k | 74.09 | |
Jazz Pharmaceuticals (JAZZ) | 0.8 | $19M | 124k | 150.99 | |
Encompass Health Corp (EHC) | 0.8 | $19M | 327k | 57.17 | |
Insmed (INSM) | 0.8 | $19M | 825k | 22.52 | |
Axogen (AXGN) | 0.8 | $18M | 505k | 36.50 | |
Ascendis Pharma A S (ASND) | 0.8 | $19M | 284k | 65.40 | |
Galapagos Nv- (GLPG) | 0.8 | $19M | 185k | 99.76 | |
Alnylam Pharmaceuticals (ALNY) | 0.7 | $17M | 143k | 119.10 | |
Audentes Therapeutics | 0.7 | $17M | 565k | 30.05 | |
Prothena (PRTA) | 0.7 | $17M | 454k | 36.71 | |
Align Technology (ALGN) | 0.7 | $16M | 66k | 251.13 | |
Zimmer Holdings (ZBH) | 0.7 | $16M | 148k | 109.04 | |
Intersect Ent | 0.7 | $16M | 410k | 39.30 | |
NuVasive | 0.7 | $16M | 305k | 52.21 | |
Theravance Biopharma (TBPH) | 0.7 | $16M | 653k | 24.25 | |
Incyte Corporation (INCY) | 0.7 | $15M | 183k | 83.33 | |
Hologic (HOLX) | 0.6 | $15M | 400k | 37.36 | |
Amicus Therapeutics (FOLD) | 0.6 | $15M | 1.0M | 15.04 | |
EXACT Sciences Corporation (EXAS) | 0.6 | $15M | 371k | 40.33 | |
Arena Pharmaceuticals | 0.6 | $15M | 375k | 39.50 | |
Biogen Idec (BIIB) | 0.6 | $15M | 53k | 273.81 | |
Blueprint Medicines (BPMC) | 0.6 | $15M | 158k | 91.70 | |
Fibrogen (FGEN) | 0.6 | $14M | 310k | 46.20 | |
Anaptysbio Inc Common (ANAB) | 0.6 | $14M | 135k | 104.08 | |
Inogen (INGN) | 0.6 | $14M | 111k | 122.84 | |
Heron Therapeutics (HRTX) | 0.6 | $13M | 476k | 27.60 | |
Menlo Therapeutics | 0.5 | $12M | 330k | 37.58 | |
Clovis Oncology | 0.5 | $12M | 232k | 52.80 | |
IDEXX Laboratories (IDXX) | 0.5 | $12M | 63k | 191.40 | |
Amarin Corporation (AMRN) | 0.5 | $12M | 4.0M | 3.01 | |
Ardelyx (ARDX) | 0.5 | $12M | 2.3M | 5.05 | |
Obseva Sa | 0.5 | $11M | 840k | 13.49 | |
Homology Medicines | 0.5 | $11M | 575k | 18.70 | |
Portola Pharmaceuticals | 0.5 | $11M | 324k | 32.66 | |
Clearside Biomedical (CLSD) | 0.5 | $11M | 975k | 10.73 | |
G1 Therapeutics | 0.5 | $11M | 287k | 37.05 | |
BioMarin Pharmaceutical (BMRN) | 0.4 | $10M | 125k | 81.07 | |
Five Prime Therapeutics | 0.4 | $10M | 586k | 17.18 | |
Adaptimmune Therapeutics (ADAP) | 0.4 | $9.8M | 875k | 11.23 | |
Aclaris Therapeutics (ACRS) | 0.4 | $9.3M | 530k | 17.52 | |
Rigel Pharmaceuticals | 0.4 | $9.1M | 2.6M | 3.54 | |
Zogenix | 0.4 | $9.0M | 226k | 40.05 | |
RTI Biologics | 0.4 | $9.0M | 2.0M | 4.60 | |
Retrophin | 0.4 | $8.9M | 400k | 22.36 | |
Ultragenyx Pharmaceutical (RARE) | 0.4 | $8.8M | 173k | 50.99 | |
Global China Cord Blood Corp (CORBF) | 0.4 | $9.0M | 880k | 10.20 | |
Achillion Pharmaceuticals | 0.4 | $8.3M | 2.3M | 3.71 | |
Zoetis Inc Cl A (ZTS) | 0.4 | $8.4M | 101k | 83.51 | |
Biohaven Pharmaceutical Holding | 0.4 | $8.4M | 325k | 25.76 | |
Odonate Therapeutics Ord | 0.3 | $8.1M | 384k | 21.18 | |
Sage Therapeutics (SAGE) | 0.3 | $7.9M | 49k | 161.06 | |
Bluebird Bio (BLUE) | 0.3 | $7.7M | 45k | 170.76 | |
Coherus Biosciences (CHRS) | 0.3 | $7.7M | 695k | 11.05 | |
Spero Therapeutics (SPRO) | 0.3 | $7.5M | 525k | 14.25 | |
Global Blood Therapeutics In | 0.3 | $7.2M | 150k | 48.30 | |
Macrogenics (MGNX) | 0.3 | $6.9M | 275k | 25.16 | |
Immunomedics | 0.3 | $6.6M | 450k | 14.61 | |
La Jolla Pharmaceuticl Com Par | 0.3 | $6.6M | 220k | 29.78 | |
Invitae (NVTAQ) | 0.3 | $6.6M | 1.4M | 4.69 | |
Corvus Pharmaceuticals (CRVS) | 0.3 | $6.6M | 575k | 11.53 | |
Momenta Pharmaceuticals | 0.3 | $6.3M | 345k | 18.15 | |
Cymabay Therapeutics | 0.3 | $6.4M | 490k | 12.99 | |
Gtx Inc Del | 0.3 | $6.3M | 354k | 17.75 | |
Myovant Sciences | 0.3 | $6.3M | 295k | 21.27 | |
Zai Lab (ZLAB) | 0.3 | $6.3M | 295k | 21.35 | |
Agilent Technologies Inc C ommon (A) | 0.3 | $6.1M | 92k | 66.90 | |
Endocyte | 0.3 | $6.1M | 675k | 9.09 | |
Novavax | 0.2 | $5.8M | 2.8M | 2.10 | |
Mirati Therapeutics | 0.2 | $5.8M | 189k | 30.70 | |
Paratek Pharmaceuticals | 0.2 | $5.9M | 450k | 13.00 | |
Shire | 0.2 | $5.6M | 38k | 149.39 | |
Therapeuticsmd | 0.2 | $5.7M | 1.2M | 4.87 | |
Insmed Inc convertible security | 0.2 | $5.3M | 6.0M | 0.89 | |
Aimmune Therapeutics | 0.2 | $5.1M | 160k | 31.83 | |
Adverum Biotechnologies | 0.2 | $5.2M | 900k | 5.80 | |
Aeglea Biotherapeutics | 0.2 | $5.2M | 524k | 9.92 | |
Clementia | 0.2 | $5.2M | 345k | 15.15 | |
Dynavax Technologies (DVAX) | 0.2 | $5.0M | 251k | 19.85 | |
Dermira | 0.2 | $4.8M | 600k | 7.99 | |
Medicines Company 2.750000 07/15/2023 bond | 0.2 | $4.8M | 5.0M | 0.96 | |
Alder Biopharmaceuticals Inc convertible security | 0.2 | $4.7M | 5.0M | 0.93 | |
BioCryst Pharmaceuticals (BCRX) | 0.2 | $4.4M | 925k | 4.77 | |
Exelixis (EXEL) | 0.2 | $3.9M | 175k | 22.15 | |
Intra Cellular Therapies (ITCI) | 0.2 | $3.9M | 188k | 21.05 | |
Compugen (CGEN) | 0.2 | $3.7M | 825k | 4.45 | |
Medicines Company conv | 0.1 | $3.5M | 3.0M | 1.15 | |
Proteostasis Therapeutics In | 0.1 | $3.2M | 675k | 4.75 | |
Merus N V (MRUS) | 0.1 | $3.2M | 175k | 18.53 | |
Ra Pharmaceuticals | 0.1 | $3.2M | 600k | 5.31 | |
Allergan | 0.1 | $3.0M | 18k | 168.30 | |
Egalet Corporation note 5.50% 4/1/20 | 0.1 | $3.1M | 7.8M | 0.40 | |
Nabriva Therapeutics | 0.1 | $3.1M | 625k | 5.03 | |
Cardiome Pharma | 0.1 | $2.8M | 1.2M | 2.32 | |
Restorbio | 0.1 | $2.6M | 275k | 9.58 | |
Dbv Technologies S A | 0.1 | $1.7M | 73k | 23.07 | |
Seres Therapeutics (MCRB) | 0.1 | $1.6M | 220k | 7.34 | |
Theravance Biopharma Inc note 3.250%11/0 | 0.1 | $1.5M | 1.5M | 1.01 | |
Radius Health Inc note 3.000% 9/0 | 0.1 | $1.5M | 1.5M | 1.01 | |
Rhythm Pharmaceuticals (RYTM) | 0.1 | $1.4M | 72k | 19.90 | |
Scynexis | 0.1 | $1.1M | 820k | 1.34 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $1.2M | 300k | 4.00 | |
Wright Med Group Inc note 2.000% 2/1 | 0.0 | $1.0M | 1.0M | 1.00 | |
Pacira Pharmaceuticals Inc convertible security | 0.0 | $910k | 1.0M | 0.91 | |
Solid Biosciences | 0.0 | $938k | 125k | 7.50 | |
Chiasma | 0.0 | $788k | 525k | 1.50 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $567k | 270k | 2.10 | |
Kura Oncology (KURA) | 0.0 | $497k | 27k | 18.75 |